CGPCS
MRNA icon

Capital Group Private Client Services’s Moderna MRNA Stock Holding History

Capital Group Private Client Services’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-36,726
Closed -$4.36M – 273
2024
Q2 		$4.36M Sell
36,726
-1,157
-3% -$146K 0.04% 175
2024
Q1 		$4.04M Buy
37,883
+7,524
+25% +$758K 0.04% 173
2023
Q4 		$3.02M Sell
30,359
-3,096
-9% -$260K 0.03% 181
2023
Q3 		$3.46M Sell
33,455
-339
-1% -$37.8K 0.04% 160
2023
Q2 		$4.11M Buy
33,794
+39
+0.1% +$5.2K 0.05% 152
2023
Q1 		$5.18M Buy
+33,755
New +$5.57M 0.06% 147

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital Group Private Client Services's MRNA Position: Q3 2024 in Review

Capital Group Private Client Services sold out of Moderna (MRNA) in Q3 2024, closing a stake of 36,726 shares — an estimated $4.36M sold.

Capital Group Private Client Services first reported a position in MRNA in Q1 2023 and held it in 6 quarters. The position peaked at $5.18M in Q1 2023. 788 funds tracked by Wall St. Rank hold MRNA as of Q3 2024.

  • Capital Group Private Client Services reported no remaining Moderna position as of Q3 2024 after selling out during the quarter.
  • Capital Group Private Client Services sold 36,726 Moderna shares in Q3 2024, an estimated $4.36M.
  • Capital Group Private Client Services first reported a position in Moderna in Q1 2023 and held it in 6 quarters.
  • Capital Group Private Client Services's Moderna position peaked at $5.18M in Q1 2023.
  • 788 funds tracked by Wall St. Rank held Moderna as of Q3 2024.

Based on Capital Group Private Client Services's 13F filing for Q3 2024, filed 13 Nov 2024.